Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL104674

CC=O.CCCC[N+](CCCC)(CCCC)CCCC

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 4/20 0.71
SLC22A2 O15244 1/20 0.61
TSHR P16473 2/20 0.55
ALDH1A1 P00352 1/20 0.55
TP53 P04637 1/20 0.55
CYP3A4 P08684 1/20 0.55
ALOX15 P16050 1/20 0.55
ALOX12 P18054 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
HIF1A Q16665 1/20 0.55
HSD17B10 Q99714 1/20 0.55
DNM1 Q05193 6/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrapentylammonium SCHEMBL11415478 0.94 SLC22A1 (0.71) SLC22A1SLC22A2TSHRALDH1A1TP53
Acetaldehyde SCHEMBL17238759 0.92 SLC22A1 (0.72) SLC22A1SLC22A2TSHRALDH1A1TP53
Acetaldehyde SCHEMBL11420862 0.92 SLC22A1 (0.72) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrahexylammonium SCHEMBL7548222 0.92 SLC22A1 (0.72) SLC22A1SLC22A2TSHRALDH1A1TP53
Acetaldehyde SCHEMBL17238774 0.92 SLC22A1 (0.72) SLC22A1SLC22A2TSHRALDH1A1TP53
Acetaldehyde SCHEMBL11424911 0.87 SLC22A1 (0.65) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL11414637 0.86 SLC22A1 (0.67) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL105861 0.86 SLC22A1 (0.67) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL29008027 0.86 SLC22A1 (0.67) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL105862 0.86 SLC22A1 (0.67) SLC22A1SLC22A2TSHRALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330311-B1 STORAGE STABLE 1K-POLYURETHANE-PREPREGS AND MOULDED ARTICLE MADE FROM SAME ON THE BASIS OF A POLYURETHANE COMPOSITION EVONIK OPERATIONS GMBH (DE) 2021-05-05 EP claimed
US-20200190261-A1 METHOD FOR PRODUCING POLYMERIC RING-OPENING PRODUCTS COVESTRO DEUTSCHLAND AG (DE) 2020-06-18 US claimed
EP-3497148-B1 METHOD FOR THE PREPARATION OF POLYMER RING OPENING PRODUCTS COVESTRO DEUTSCHLAND AG (DE) 2020-06-03 EP claimed
US-10626236-B2 Storage-stable one-component polyurethane prepregs and shaped bodies composed of polyurethane composition that have been produced therefrom EVONIK OPERATIONS GMBH (DE) 2020-04-21 US claimed
US-20180155515-A1 STORAGE-STABLE ONE-COMPONENT POLYURETHANE PREPREGS AND SHAPED BODIES COMPOSED OF POLYURETHANE COMPOSITION THAT HAVE BEEN PRODUCED THEREFROM EVONIK OPERATIONS GMBH (DE) 2018-06-07 US claimed
EP-2362809-A2 PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE Akermin, Inc. (US) 2011-09-07 EP claimed
WO-2010037109-A2 PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE AKERMIN, INC. (US) 2010-04-01 WO claimed
WO-2024110999-A1 PROCESS FOR THE PREPARATION OF HIGHLY PURE SULFENTRAZONE JDM SCIENTIFIC RESEARCH ORGANISATION PRIVATE LIMITED (IN) 2024-05-30 WO disclosed
EP-3204146-B1 PROCESSES FOR CARBON DIOXIDE CAPTURE WITH BIOCATALYST RECOVERY SYSTEM SAIPEM SPA (IT) 2022-12-07 EP disclosed
CN-109937197-B Electrochemical process for preparing aryl alkyl carbonates and diaryl carbonates 科思创德国股份有限公司 2022-05-03 CN disclosed
US-10793664-B2 Process for preparing trimers and/or oligomers of diisocyanates EVONIK OPERATIONS GMBH (DE) 2020-10-06 US disclosed
US-20200190261-A1 METHOD FOR PRODUCING POLYMERIC RING-OPENING PRODUCTS COVESTRO DEUTSCHLAND AG (DE) 2020-06-18 US disclosed
US-10336856-B2 Alkoxysilane- and allophanate-functionalized coating materials EVONIK DEGUSSA GMBH (DE) 2019-07-02 US disclosed
EP-0920403-A1 PROCESS FOR PREPARING CYCLOPENTADIENYL COMPOUNDS Montell Technology Company bv (NL) 1999-06-09 EP disclosed
EP-0910560-A1 PROCESS FOR PREPARING 2-ARYL-SUBSTITUTED INDENES Montell Technology Company bv (NL) 1999-04-28 EP disclosed
WO-1998046547-A1 PROCESS FOR PREPARING 2-ARYL-SUBSTITUTED INDENES MONTELL TECHNOLOGY COMPANY B.V. (NL) 1998-10-22 WO disclosed
WO-1998043931-A1 PROCESS FOR PREPARING CYCLOPENTADIENYL COMPOUNDS MONTELL TECHNOLOGY COMPANY B.V. (NL) 1998-10-08 WO disclosed
US-5516878-A CATALYTIC ESTER INTERCHANGE USING AN ALKALI METAL SALT OF AN ATE-COMPLEX OF A METAL SELECTED FROM SILICON, GERMANIUM, TIN, OR LEAD TEIJIN LIMITED (JP) 1996-05-14 US disclosed
EP-0667366-A2 Process for the production of aromatic polycarbonate TEIJIN LIMITED (JP) 1995-08-16 EP disclosed
US-4209643-A Preparation of acetals ETHYL CORPORATION (US) 1980-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336856-B2 Alkoxysilane- and allophanate-functionalized coating materials DDAH1, OR10J3, AP3S1 SLC22A1 1697/4885SLC22A2 2277/4885TSHR 4762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.